Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00432-016-2329-7
Published Online: 2017-01-06
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Imataki, Osamu
Matsumoto, Kensuke
Uemura, Makiko
License valid from 2017-01-06
